University of Nottingham
  • Print
  

BLISTER study results published in The Lancet

The BLISTER Study investigated the treatments for bullous pemphigoid, a severe blistering skin condition. Results showed that starting treatment with an oral antibiotic (doxycycline) is an effective and safer alternative to the current standard treatment of oral steroids (prednisolone) which can have harmful long-term side effects.

This was a large study on a rare disease so we are particularly delighted to have completed such a meaningful trial with potentially practice changing results. This simply couldn’t have been achieved without the UK DCTN membership who supported this study - their time and commitment as investigators on this study was crucial to it's success.

You can see full details of this NIHR HTA funded study in The Lancet:
http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(17)30560-3/fulltext?elsca1=tlxpr

UK DCTN Chair Prof Hywel Williams describes the study results in this short video on the BLISTER Study website:
http://www.nottingham.ac.uk/research/groups/cebd/projects/5rareandother/blistertrial.aspx

Posted on Wednesday 8th March 2017

UK Dermatology Clinical Trials Network


Centre of Evidence Based Dermatology
The University of Nottingham King's Meadow Campus, Rm A103
Lenton Lane, Nottingham
NG7 2NR, UK

Email: UKDCTN@nottingham.ac.uk